Impact of Pexelizumab,an anti - C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopuhnonary bypass

查看全文 作　　者：Shernan SK; Fitch JC; Nussmeier NA; 出　　处：《Ann Thorac Surg》索引2004年第77卷第3期,共0页